Loading...

MNKD MANNKIND CORP Company Mergers 8-K Filing

MNNK

MNKD

MANNKIND CORP

(MNKD)

2025 8-K

Earnings Report

MannKind Announcement

Filing Amendment

Trial Discontinuation

Financial Update

MannKind Acquisition

Collaboration Expansion

Merger Agreement Signed

Financial Statements

Financial Statements

Financial Results

Management Change

Equity Exchange

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

CFO Retirement and Appointment

Earnings Reports

Agreement with Sagard Healt...

Supply Agreement Amendment

Earnings Reports

Earnings Reports

Annual Meeting Approval

Earnings Reports

External Links:

On August 24, 2025, MannKind Corporation signed an amendment with United Therapeutics to expand their collaboration, receiving an upfront payment of $5 million and the potential for $35 million in milestones plus royalties on future sales of a new product.

AI Assistant

MANNKIND CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.